Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 42,146 |
|
|||||
| News | - | ||||||
| Day High | 1.285 | Low High |
|||||
| Day Low | 1.17 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| NeuroSense Therapeutics Ltd | NRSN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.03 | -2.38% | 1.23 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.24 | 1.17 | 1.285 | 1.23 | 1.26 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 164 | 42,146 | US$ 1.25 | US$ 52,624 | - | 0.40 - 2.33 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:56:43 | 40 | US$ 1.28 | USD |
NeuroSense Therapeutics Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.42M | 11.79M | - | 0 | -11.28M | -0.96 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
NeuroSense Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NRSN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.49 | 1.53 | 1.11 | 1.35 | 164,129 | -0.26 | -17.45% |
| 1 Month | 1.82 | 2.25 | 1.11 | 1.66 | 203,547 | -0.59 | -32.42% |
| 3 Months | 1.30 | 2.33 | 1.10 | 1.65 | 306,607 | -0.07 | -5.38% |
| 6 Months | 0.49 | 2.33 | 0.4011 | 1.17 | 547,602 | 0.74 | 151.02% |
| 1 Year | 2.12 | 2.33 | 0.40 | 1.13 | 334,342 | -0.89 | -41.98% |
| 3 Years | 4.55 | 8.18 | 0.40 | 3.55 | 1,174,927 | -3.32 | -72.97% |
| 5 Years | 4.55 | 8.18 | 0.40 | 3.55 | 1,174,927 | -3.32 | -72.97% |
NeuroSense Therapeutics Description
| NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its lead product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio. |
